The latest closing stock price for Rapt Therapeutics as of February 21, 2025 is 1.25.
An investor who bought $1,000 worth of Rapt Therapeutics stock at the IPO in 2019 would have $-902 today, roughly -1 times their original investment - a -37.10% compound annual growth rate over 5 years.
The all-time high Rapt Therapeutics stock closing price was 48.86 on January 27, 2020.
The Rapt Therapeutics 52-week high stock price is 10.05, which is 704% above the current share price.
The Rapt Therapeutics 52-week low stock price is 0.79, which is 36.8% below the current share price.
The average Rapt Therapeutics stock price for the last 52 weeks is 3.52.
An investor who bought $1,000 worth of Rapt Therapeutics stock at the IPO in 2019 would have $-902 today, roughly -1 times their original investment - a -37.10% compound annual growth rate over 5 years.
The all-time high Rapt Therapeutics stock closing price was 48.86 on January 27, 2020.
The Rapt Therapeutics 52-week high stock price is 10.05, which is 704% above the current share price.
The Rapt Therapeutics 52-week low stock price is 0.79, which is 36.8% below the current share price.
The average Rapt Therapeutics stock price for the last 52 weeks is 3.52.